Pages that link to "Q37359663"

The following pages link to Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases (Q37359663):

Displaying 26 items.

• Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization (Q26771165) (← links)
• Targeting autophagy in cancer management - strategies and developments (Q26782468) (← links)
• Therapeutic Targeting of Autophagy (Q28078117) (← links)
• Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors (Q28468571) (← links)
• Chloroquine is a zinc ionophore (Q28543470) (← links)
• Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy (Q36208147) (← links)
• Autophagy and human diseases (Q37429062) (← links)
• Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors (Q37701461) (← links)
• Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies. (Q38600792) (← links)
• Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy (Q38795278) (← links)
• Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram? (Q41180131) (← links)
• NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy (Q41911962) (← links)
• Targeting autophagy in cancer (Q41912265) (← links)
• FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results (Q41921083) (← links)
• Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer (Q42409837) (← links)
• Effects of chronic exposure of hydroxychloroquine/chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseases. (Q47138361) (← links)
• Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. (Q47162451) (← links)
• Lysosome-targeting agents in cancer therapy (Q49298793) (← links)
• Chemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors (Q59133202) (← links)
• The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: A systematic review and meta-analysis (Q60054140) (← links)
• Targeting autophagy in cancer (Q88406511) (← links)
• Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7 (Q90090983) (← links)
• Cellular Stress Responses in Radiotherapy (Q90195204) (← links)
• Autophagy, cancer stem cells and drug resistance (Q90661029) (← links)
• Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients (Q91973791) (← links)
• Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial (Q97543212) (← links)